News & Updates
Filter by Specialty:
Door-to-balloon time can be more lenient in STEMI not complicated by cardiogenic shock
A longer DTBT of up to 180 min is not associated with worse clinical outcomes at 30 days and 1 year in patients with STEMI presenting in Killip classes I–III, according to an analysis of data from the Singapore Myocardial Infarction Registry
Door-to-balloon time can be more lenient in STEMI not complicated by cardiogenic shock
30 Oct 2024
Beta blocker adjustment shows no impact on tachyarrhythmias in admitted HFrEF patients
Holding or decreasing the dose of outpatient beta blocker therapy does not seem to affect the incidence of tachyarrhythmias in patients with heart failure with reduced ejection fraction (HFrEF) admitted for acute decompensated heart failure (ADHF), reports a study.
Beta blocker adjustment shows no impact on tachyarrhythmias in admitted HFrEF patients
29 Oct 2024
Happiness is key to a healthy heart
An analysis using the UK Biobank dataset shows a robust inverse association between well-being and risk of cardiovascular diseases (CVDs), underpinning the protective effect of higher well-being on the four major CVDs evaluated: coronary heart disease, MI, heart failure (HF), and stroke.
Happiness is key to a healthy heart
29 Oct 2024
Insulin resistance linked to future hypertension in normotensive salt-sensitive individuals
A 10-year study has found the association of salt sensitivity with insulin resistance and endothelial dysfunction in the offspring of hypertensive salt-sensitive parents, making them susceptible to developing hypertension.
Insulin resistance linked to future hypertension in normotensive salt-sensitive individuals
28 Oct 2024
Semaglutide helps prevent HF events, CV death in diabetic patients with CKD
Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.